Detalhe da pesquisa
1.
Evaluation of a Fully Human, Hepatitis B Virus-Specific Chimeric Antigen Receptor in an Immunocompetent Mouse Model.
Mol Ther
; 27(5): 947-959, 2019 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30852138
2.
CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting target hepatitis B virus-positive cells.
Front Immunol
; 15: 1340619, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711498
3.
Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins.
Front Immunol
; 13: 1029214, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36405686
4.
Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B.
Front Immunol
; 12: 734246, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34691041
5.
Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors.
Mol Ther Methods Clin Dev
; 23: 476-489, 2021 Dec 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34853796
6.
Adoptive T-cell therapy for HBV-associated HCC and HBV infection.
Antiviral Res
; 176: 104748, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32087191
7.
Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.
PLoS One
; 12(8): e0182936, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28792537